Thiazole derivatives as phosphodiesterase IV inhibitors

Details for Australian Patent Application No. 2003232215 (hide)

Owner Merck Patent GmbH

Inventors Wolf, Michael; Egggenweiler, HansMichael

Agent Davies Collison Cave

Pub. Number AU-B-2003232215

PCT Number PCT/EP03/04434

PCT Pub. Number WO2004/000839

Priority 102 27 269.7 19.06.02 DE

Filing date 28 April 2003

Wipo publication date 6 January 2004

Acceptance publication date 30 April 2009

International Classifications

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/14 (2006.01) Drugs for disorders of the endocrine system

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/02 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 11/08 (2006.01) Drugs for disorders of the respiratory system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 17/04 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/06 (2006.01) Drugs for skeletal disorders

Event Publications

28 August 2003 Complete Application Filed

  Priority application(s): 102 27 269.7 19.06.02 DE

4 March 2004 Application Open to Public Inspection

  Published as AU-B-2003232215

30 April 2009 Application Accepted

  Published as AU-B-2003232215

28 May 2009 Application for Amendment

  The nature of the amendment is: Amend the co-inventor name from Egggenweiler, Hans-Michael to Eggenweiler, Hans-Michael. Address for service in Australia - Davies Collison Cave 255 Elizabeth Street Sydney NSW 2000

10 September 2009 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Eggenweiler, Hans-Michael

17 September 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003232216-TEMPERATURE COMPENSATION OF A SENSOR ARRANGEMENT (GMR) WITH DOUBLE-SIDED POTENTIAL CHANGES

2003232214-PRINTING SYSTEM